Comment on CMS-2026-1255-0001

Summary: Susan G. Komen, a nonprofit breast cancer organization, supports the proposed rule to streamline and standardize electronic prior authorization (PA) for prescription drugs. They advocate for further improvements, including shorter response timeframes, requirements for PA validity during the duration of treatment, and a prohibition on step therapy for patients with metastatic cancer.